Elanco Animal Financials
ELAN Stock | USD 10.53 0.05 0.47% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.56 | 0.7088 |
|
| |||||
Operating Income | 266.3 M | 251 M |
|
| |||||
Current Ratio | 2.78 | 2.4449 |
|
|
Investors should never underestimate Elanco Animal's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Elanco Animal's cash flow, debt, and profitability to make informed and accurate decisions about investing in Elanco Animal Health.
Net Income |
|
Elanco | Select Account or Indicator |
Understanding current and past Elanco Animal Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Elanco Animal's financial statements are interrelated, with each one affecting the others. For example, an increase in Elanco Animal's assets may result in an increase in income on the income statement.
Elanco Animal Health Earnings Geography
Elanco Animal Stock Summary
Elanco Animal competes with Viatris, Lantheus Holdings, Haleon Plc, Phibro Animal, and Prestige Brand. Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. Elanco Animal operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 9000 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US28414H1032 |
CUSIP | 28414H103 |
Location | Indiana; U.S.A |
Business Address | 2500 Innovation Way, |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.elanco.com |
Phone | 877 352 6261 |
Currency | USD - US Dollar |
Elanco Animal Key Financial Ratios
Return On Equity | 0.0549 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.01 % | ||||
Price To Sales | 1.17 X | ||||
Revenue | 4.44 B |
Elanco Animal Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 17.7B | 16.5B | 15.5B | 14.4B | 12.6B | 13.6B | |
Other Current Liab | 983.8M | 903M | 924M | 933M | 975M | 777.7M | |
Other Liab | 228.2M | 1.3B | 1.2B | 941M | 1.1B | 780.6M | |
Net Tangible Assets | 74.5M | (4.1B) | (4.3B) | (3.5B) | (3.2B) | (3.0B) | |
Net Debt | 5.6B | 5.7B | 5.5B | 5.4B | 3.9B | 3.6B | |
Retained Earnings | (477.2M) | (949M) | (1.1B) | (2.3B) | (2.0B) | (1.9B) | |
Accounts Payable | 501M | 416M | 390M | 270M | 296M | 334.0M | |
Cash | 494.7M | 638M | 345M | 352M | 468M | 450.8M | |
Other Assets | 78.9M | 127.3M | 183M | 193M | 173.7M | 123.4M | |
Net Receivables | 1.1B | 1.0B | 1.0B | 1.0B | 886M | 957.6M | |
Good Will | 6.2B | 6.2B | 6.0B | 5.1B | 4.4B | 4.8B | |
Inventory | 1.6B | 1.4B | 1.5B | 1.7B | 1.6B | 1.4B | |
Other Current Assets | 267M | 325M | 394M | 310M | 287M | 257.0M | |
Total Liab | 9.2B | 8.9B | 8.2B | 8.1B | 6.5B | 6.2B | |
Total Current Assets | 3.4B | 3.3B | 3.3B | 3.4B | 3.2B | 3.1B | |
Intangible Assets | 6.4B | 5.6B | 4.8B | 4.5B | 3.7B | 4.3B | |
Net Invested Capital | 14.6B | 13.9B | 13.1B | 12.0B | 10.4B | 12.0B | |
Net Working Capital | 1.3B | 1.6B | 1.6B | 2.2B | 1.9B | 1.8B | |
Long Term Debt | 5.6B | 6.0B | 5.4B | 5.7B | 4.3B | 5.0B | |
Capital Surpluse | 5.6B | 8.7B | 8.7B | 8.7B | 10.0B | 8.2B | |
Short Long Term Debt | 554.5M | 294M | 388M | 38M | 44M | 41.8M | |
Short Term Debt | 591.5M | 328M | 388M | 38M | 44M | 41.8M |
Elanco Animal Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Tax Provision | (111.9M) | (95M) | 8M | (13M) | 150M | 157.5M | |
Interest Expense | 149.8M | 236M | 241M | 277M | 235M | 137.2M | |
Total Revenue | 3.3B | 4.8B | 4.4B | 4.4B | 4.4B | 4.0B | |
Gross Profit | 1.6B | 2.6B | 2.5B | 1.9B | 1.9B | 2.0B | |
Operating Income | 101.5M | 297M | 358M | 326M | 251M | 266.3M | |
Ebit | (593.7M) | (307M) | 184M | (918M) | 723M | 759.2M | |
Research Development | 270.1M | 327M | 369M | 321M | 344M | 331.5M | |
Ebitda | (76.8M) | 409M | 866M | (224M) | 1.4B | 1.5B | |
Cost Of Revenue | 1.7B | 2.1B | 1.9B | 2.5B | 2.5B | 2.0B | |
Income Before Tax | (672M) | (567M) | (66M) | (1.2B) | 488M | 512.4M | |
Net Income | (560.1M) | (472M) | (74M) | (1.2B) | 338M | 354.9M | |
Income Tax Expense | (111.9M) | (95M) | 8M | 36M | 150M | 157.5M | |
Net Interest Income | (149.8M) | (236M) | (241M) | (272M) | (235M) | (246.8M) | |
Non Recurring | 185.5M | 623.7M | 628M | 183M | 210.5M | 384.8M |
Elanco Animal Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | (94.7M) | 27M | (269M) | (160M) | 44M | 46.2M | |
Change In Cash | 160.3M | 132M | (293M) | 7M | 116M | 121.8M | |
Net Borrowings | (121.1M) | 3.8B | 241M | (518M) | (466.2M) | (442.9M) | |
Free Cash Flow | (351.9M) | 286M | 268M | 117M | 394M | 413.7M | |
Depreciation | 516.9M | 716M | 682M | 694M | 662M | 516.0M | |
Other Non Cash Items | (86.4M) | 414M | 308M | 1.1B | (551M) | (523.5M) | |
Capital Expenditures | 310.9M | 197M | 184M | 154M | 147M | 179.7M | |
Net Income | (560.1M) | (472M) | (78M) | (1.2B) | 338M | 354.9M | |
End Period Cash Flow | 505.4M | 638M | 345M | 352M | 468M | 481.1M | |
Change To Netincome | 36.8M | (278.7M) | 326M | 22M | 25.3M | 47.7M | |
Investments | 32.7M | (530M) | (179M) | (210M) | 1.2B | 1.2B |
Elanco Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elanco Animal's current stock value. Our valuation model uses many indicators to compare Elanco Animal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elanco Animal competition to find correlations between indicators driving Elanco Animal's intrinsic value. More Info.Elanco Animal Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Elanco Animal Health is roughly 4.61 . At this time, Elanco Animal's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elanco Animal's earnings, one of the primary drivers of an investment's value.Elanco Animal's Earnings Breakdown by Geography
Elanco Animal Health Systematic Risk
Elanco Animal's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Elanco Animal volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Elanco Animal Health correlated with the market. If Beta is less than 0 Elanco Animal generally moves in the opposite direction as compared to the market. If Elanco Animal Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Elanco Animal Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Elanco Animal is generally in the same direction as the market. If Beta > 1 Elanco Animal moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Elanco Animal Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Elanco Animal's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Elanco Animal growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Elanco Animal March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Elanco Animal help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Elanco Animal Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Elanco Animal Health based on widely used predictive technical indicators. In general, we focus on analyzing Elanco Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Elanco Animal's daily price indicators and compare them against related drivers.
Information Ratio | (0.06) | |||
Maximum Drawdown | 11.55 | |||
Value At Risk | (3.76) | |||
Potential Upside | 2.86 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.